Painless glucose check? new device could end finger pricks

NCT ID NCT07088497

Completed Diagnosis Sponsor: Revlis Biotech Company Limited Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new device called the Cmate blood glucose analyzer, which measures blood sugar without needing a finger prick. Researchers compared its readings to standard blood tests in 40 healthy, pre-diabetic, and diabetic adults. The goal is to see if this non-invasive method is accurate enough for home use, potentially making blood sugar monitoring less painful and more convenient.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: non-invasive blood glucose measurement system
What this could lead to: If successful, this could lead to a painless, needle-free way to monitor blood glucose, making regular checks easier for people with diabetes.
What could go wrong: This is a small, early-stage study with only 40 participants. The device is not yet FDA-approved and may not be as accurate as traditional methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus prediabetes syndrome type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES GLUCOSE

Contacts and locations

Locations

Taipei Medical University Shuang Ho Hospital

New Taipei City, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.